Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.

Scientific reports - 4 Feb 2022

Zeng Yudan, Lin Dongtao, Gao Mengqian, Du Guoxia, Cai Yongming

Abstract excerpt

The protein PDLIM2 regulates the stability of various transcription factors and is required for polarized cell migration. However, the clinical relevance and immune infiltration of PDLIM2 in cancer are not well-understood. We utilized The Cancer Genome Atlas and Genotype-Tissue Expression database to characterize alterations in PDLIM2 in pan-cancer. TIMER was used to explore PDLIM2 expression and immune...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to LIM Domain Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microfilament Proteins

Share to Microsatellite Instability

Share to Mutation

Share to Neoplasms

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 35121770
DOI: 10.1038/s41598-022-05987-1
PMCID: PMC8817018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.PMID 35121770Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerSemantic proximity Read ↗

Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistanceSemantic proximity Read ↗

The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.Semantic proximity Read ↗

PDLIM1: Structure, function and implication in cancerSemantic proximity Read ↗

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer typesSemantic proximity Read ↗

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-CancerSemantic proximity Read ↗

An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.Semantic proximity Read ↗

Divergent roles of PKM2 in regulating PD-L1 and PD-L2 expression and their implications in human and mouse cancer modelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.